Cognitive-Behavioral Therapy and Pharmacotherapy Augmentation for Generalized Anxiety Disorder: A Pilot Investigation.
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2017
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- 11 Apr 2012 Actual patient number amended from 26 to 25 and primary endpoint added as reported by ClinicalTrials.gov.
- 14 Dec 2011 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 14 Dec 2011 Actual initiation date changed from Mar 2005 to Jan 2005 as reported by ClinicalTrials.gov.